The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as a genetic instruction book, telling cells to produce therapeutic or ...

About Mana.bio Mana.bio is a biotechnology company revolutionizing targeted RNA delivery using artificial intelligence-enabled LNP discovery and optimization. This approach accelerates research ...

A New Standard in LNP Characterization for Biopharma LNPs play a pivotal role in the development of RNA therapeutics, gene editing, and targeted drug delivery systems. However, traditional methods of ...

The structure of CL4F 8-6, the branched ionizable lipid that was most effective in increasing storage stability and LNP-RNA delivery (Image: Yusuke Sato).

CPD-accredited course delivered in an engaging way by our incredible RNA and LNP experts with videos and animation. There's also the opportunity to ask any burning questions in a dedicated Q&A session ...

Pieter Cullis a co-founder and have shares in Acuitas Therapeutics, the company that provided the LNP enabling the Pfizer ... This revolution is being powered by RNA technology — and Canada ...

May 7, 2025 /PRNewswire/ -- Mana.bio, a biotechnology company leveraging artificial intelligence (AI) and nanotechnology for targeted RNA delivery ... AI / ML to design LNP for delivering nucleic ...